Tendim SRL
3.2 FTEThe score of Tendim shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +33 % Total assets +20 % Headcount (avg FTE) +14 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tendim's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 5,401 € | ||||
| Equity | 616,476 € | ||||
| Cash | 220,597 € | ||||
| EBITDA | 24,511 € | ||||
| Total assets | 953,104 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 08 May 2026
- Year ended 30 Sep 2024filed on 12 May 2025
- Year ended 30 Sep 2023filed on 14 May 2024
- Year ended 30 Sep 2022filed on 29 Apr 2023
- Year ended 30 Sep 2021filed on 30 Apr 2022
Tendim's financial analysis
- Solvency64.7%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tendim
Tendim's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.845.781
- VAT number
- BE0474845781
- Peppol
- Registered · 0208:0474845781 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 May 2001
- Registered office
- 2570 Duffel
- Size
- Micro · 3.2 FTE
- Latest accounts
- 2025 · filed on 08 May 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Tendim (SRL) has been based in Duffel since 2001, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 5,401 € and equity of 616,476 €; its revenue is not published. With 3.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 64.7%, above the median of its sector (46.0%).
Companies similar to Tendim
Companies in the same business, of comparable size and area, outside its group.
- Farla Medical Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 895,466 €
- Prime Medical Solutions Wholesale of pharmaceutical and medical goods Hasselt · balance sheet 975,003 €
- Medico Wholesale of pharmaceutical and medical goods Grimbergen · balance sheet €1.05m
- GD Medical Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €1.09m
- Cutera Wholesale of pharmaceutical and medical goods Brussels · balance sheet €1.13m
- Odontos Handel BE Wholesale of pharmaceutical and medical goods Temse · balance sheet 779,265 €
- Imlab Wholesale of pharmaceutical and medical goods Glabbeek · balance sheet 767,272 €
- ProCare België Wholesale of pharmaceutical and medical goods Leuven · balance sheet 730,333 €
Frequently asked questions about Tendim
What is the revenue of Tendim?
Tendim files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tendim?
In Belgium, the VAT number is the company number prefixed with BE: BE0474845781 for Tendim, if the company is VAT-registered. Its company number (CBE) is 0474.845.781.
Where is the registered office of Tendim?
According to the CBE register, the registered office of Tendim is in 2570 Duffel.
What is the equity of Tendim?
At the close of the 2025 financial year, the equity of Tendim amounts to 616,476 €, a solvency of 64.7% of total assets.
How many people work at Tendim?
3.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Tendim?
The register lists 2 active mandates at Tendim. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Tendim
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →